Skip to main content

MAPK and NF-κB Pathways Are Involved in Bisphenol A-Induced TNF-α and IL-6 Production in BV2 Microglial Cells

Abstract

Microglial activation has been reported to play an important role in neurodegenerative diseases by producing pro-inflammatory cytokines. Bisphenol A (BPA, 2,2-bis (4-hydroxyphenyl) propane), known as a ubiquitous endocrine-disrupting chemical, is reported to perform both mimic- and anti-estrogen properties; however, whether it affects cytokine production or immune response in central nervous system remains unclear. The present study was aimed to explore whether BPA was involved in inflammatory action and to investigate the potential mechanisms in microglial cells. BV2, the murine microglial cell line, was used in the present work as the cell model. BPA-associated morphologic changes, cytokine responses, and signaling events were examined using immunofluorescence analysis, real-time PCR, enzyme-linked immunosorbent assay, and western blot. Our results indicated that BPA increased BV2 cells activation and simultaneously elevated tumor necrosis factor-α and interleukin 6 expression, which could be partially reversed by estrogen receptor antagonist, ICI182780. In addition, the c-Jun N-terminal protein kinase (JNK) inhibitor (SP600125), rather than ERK1/2 blocker (PD98059), displayed anti-inflammatory properties on BPA-elicited cytokine responses. Moreover, the inflammatory transcription factor NF-κB was specifically activated by BPA as well. These results, taken together, suggested that BPA may have functional effects on the response of microglial cell activation via, in part, the estrogen receptor, JNK, ERK mitogen-activated protein kinase, and NF-κB signaling pathways with its subsequent influence on pro-inflammatory action.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

REFERENCES

  1. Schug, T.T., A. Janesick, B. Blumberg, and J.J. Heindel. 2011. Endocrine disrupting chemicals and disease susceptibility. The Journal of Steroid Biochemistry and Molecular Biology 127: 204–215.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  2. Casals-Casas, C., and B. Desvergne. 2011. Endocrine disruptors: from endocrine to metabolic disruption. Annual Review of Physiology 73: 135–162.

    CAS  PubMed  Article  Google Scholar 

  3. DiVall, S.A. 2013. The influence of endocrine disruptors on growth and development of children. Current Opinion in Endocrinology Diabetes and Obesity 20: 50–55.

    CAS  Article  Google Scholar 

  4. Crisp, T.M., E.D. Clegg, R.L. Cooper, W.P. Wood, D.G. Anderson, K.P. Baetcke, J.L. Hoffmann, M.S. Morrow, D.J. Rodier, J.E. Schaeffer, L.W. Touart, M.G. Zeeman, and Y.M. Patel. 1998. Environmental endocrine disruption: an effects assessment and analysis. Environmental Health Perspectives 106(Suppl 1): 11–56.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  5. Fernandez, M.F., B. Olmos, A. Granada, M.J. Lopez-Espinosa, J.M. Molina-Molina, J.M. Fernandez, M. Cruz, F. Olea-Serrano, and N. Olea. 2007. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study. Environmental Health Perspectives 115(Suppl 1): 8–14.

    PubMed Central  PubMed  Article  Google Scholar 

  6. Elsworth, J.D., J.D. Jentsch, C.A. Vandevoort, R.H. Roth, D.E. Jr, and C. Leranth. 2013. Prenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates. Neurotoxicology 35: 113–120.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  7. Maffini, M.V., B.S. Rubin, C. Sonnenschein, and A.M. Soto. 2006. Endocrine disruptors and reproductive health: the case of bisphenol-A. Molecular and Cellular Endocrinology 254–255: 179–186.

    PubMed  Article  Google Scholar 

  8. Richter, C.A., L.S. Birnbaum, F. Farabollini, R.R. Newbold, B.S. Rubin, C.E. Talsness, J.G. Vandenbergh, D.R. Walser-Kuntz, and F.S. vom Saal. 2007. In vivo effects of bisphenol A in laboratory rodent studies. Reproductive Toxicology 24: 199–224.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  9. Kim, M.E., H.R. Park, E.J. Gong, S.Y. Choi, H.S. Kim, and J. Lee. 2011. Exposure to bisphenol A appears to impair hippocampal neurogenesis and spatial learning and memory. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 49: 3383–3389.

    CAS  Article  Google Scholar 

  10. Yang, L., L. Luo, W. Ji, C. Gong, D. Wu, H. Huang, Q. Liu, B. Xia, G. Hu, W. Zhang, Q. Zhang, J. Liu, and Z. Zhuang. 2013. Effect of low dose bisphenol A on the early differentiation of human embryonic stem cells into mammary epithelial cells. Toxicology Letters 218: 187–193.

    CAS  PubMed  Article  Google Scholar 

  11. Rogers, J.A., L. Metz, and V.W. Yong. 2013. Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Molecular Immunology 53: 421–430.

    CAS  PubMed  Article  Google Scholar 

  12. Meeker, J.D., and K.K. Ferguson. 2011. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environmental Health Perspectives 119: 1396–1402.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  13. Kubo, K., O. Arai, M. Omura, R. Watanabe, R. Ogata, and S. Aou. 2003. Low dose effects of bisphenol A on sexual differentiation of the brain and behavior in rats. Neuroscience Research 45: 345–356.

    CAS  PubMed  Article  Google Scholar 

  14. Liu, C., W. Duan, R. Li, S. Xu, L. Zhang, C. Chen, M. He, Y. Lu, H. Wu, H. Pi, X. Luo, Y. Zhang, M. Zhong, Z. Yu, and Z. Zhou. 2013. Exposure to bisphenol A disrupts meiotic progression during spermatogenesis in adult rats through estrogen-like activity. Cell Death and Disease 4: e676.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  15. Spence, R.D., A.J. Wisdom, Y. Cao, H.M. Hill, C.R. Mongerson, B. Stapornkul, N. Itoh, M.V. Sofroniew, and R.R. Voskuhl. 2013. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERalpha signaling on astrocytes but not through ERbeta signaling on astrocytes or neurons. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 33: 10924–10933.

    CAS  Article  Google Scholar 

  16. Gosselin, D., and S. Rivest. 2011. Estrogen receptor transrepresses brain inflammation. Cell 145: 495–497.

    CAS  PubMed  Article  Google Scholar 

  17. Spence, R.D., and R.R. Voskuhl. 2012. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Frontiers in Neuroendocrinology 33: 105–115.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  18. Loram, L.C., P.W. Sholar, F.R. Taylor, J.L. Wiesler, J.A. Babb, K.A. Strand, D. Berkelhammer, H.E. Day, S.F. Maier, and L.R. Watkins. 2012. Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats. Psychoneuroendocrinology 37: 1688–1699.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  19. Graeber, M.B., W. Li, and M.L. Rodriguez. 2011. Role of microglia in CNS inflammation. FEBS Letters 585: 3798–3805.

    CAS  PubMed  Article  Google Scholar 

  20. Zhang, W., K. Phillips, A.R. Wielgus, J. Liu, A. Albertini, F.A. Zucca, R. Faust, S.Y. Qian, D.S. Miller, C.F. Chignell, B. Wilson, V. Jackson-Lewis, S. Przedborski, D. Joset, J. Loike, J.S. Hong, D. Sulzer, and L. Zecca. 2011. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. Neurotoxicity Research 19: 63–72.

    PubMed Central  PubMed  Article  Google Scholar 

  21. Glass, C.K., K. Saijo, B. Winner, M.C. Marchetto, and F.H. Gage. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918–934.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  22. Glezer, I., A.R. Simard, and S. Rivest. 2007. Neuroprotective role of the innate immune system by microglia. Neuroscience 147: 867–883.

    CAS  PubMed  Article  Google Scholar 

  23. Choi, Y., M.K. Lee, S.Y. Lim, S.H. Sung, and Y.C. Kim. 2009. Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells. British Journal of Pharmacology 156: 933–940.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  24. Cordle, A., and G. Landreth. 2005. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25: 299–307.

    CAS  Article  Google Scholar 

  25. Tabb, M.M., and B. Blumberg. 2006. New modes of action for endocrine-disrupting chemicals. Molecular Endocrinology 20: 475–482.

    CAS  PubMed  Article  Google Scholar 

  26. Carnevale, D., R. De Simone, and L. Minghetti. 2007. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS & Neurological Disorders Drug Targets 6: 388–397.

    CAS  Article  Google Scholar 

  27. Bhat, N.R., P. Zhang, J.C. Lee, and E.L. Hogan. 1998. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. The Journal of Neuroscience : the Official Journal of the Society for Neuroscience 18: 1633–1641.

    CAS  Google Scholar 

  28. Roy, A., Y.K. Fung, X. Liu, and K. Pahan. 2006. Up-regulation of microglial CD11b expression by nitric oxide. The Journal of Biological Chemistry 281: 14971–14980.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  29. Baker, A.E., V.M. Brautigam, and J.J. Watters. 2004. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 145: 5021–5032.

    CAS  PubMed  Article  Google Scholar 

  30. Laurenzi, M., C. Arcuri, R. Rossi, P. Marconi, and V. Bocchini. 2001. Effects of microenvironment on morphology and function of the microglial cell line BV-2. Neurochemical Research 26: 1209–1216.

    CAS  PubMed  Article  Google Scholar 

  31. Glenn, J.A., S.A. Ward, C.R. Stone, P.L. Booth, and W.E. Thomas. 1992. Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability. Journal of Anatomy 180(Pt 1): 109–118.

    PubMed Central  PubMed  Google Scholar 

  32. Yamashita, U., T. Sugiura, Y. Yoshida, and E. Kuroda. 2005. Effect of endocrine disrupters on macrophage functions in vitro. Journal of UOEH 27: 1–10.

    CAS  PubMed  Google Scholar 

  33. Young Kim, J., and H. Gwang Jeong. 2003. Down-regulation of inducible nitric oxide synthase and tumor necrosis factor-α expression by bisphenol A via nuclear factor-κB inactivation in macrophages. Cancer Letters 196: 69–76.

    Article  Google Scholar 

  34. Vandenberg, L.N. 2014. Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study. Dose-Response 1: 1–18.

    Article  Google Scholar 

  35. Wang, H., Q. Wang, U.J. Pape, B. Shen, J. Huang, B. Wu, and X. Li. 2010. Systematic investigation of global coordination among mRNA and protein in cellular society. BMC Genomics 11: 364.

    PubMed Central  PubMed  Article  Google Scholar 

  36. Straub, R.H. 2007. The complex role of estrogens in inflammation. Endocrine Reviews 28: 521–574.

    CAS  PubMed  Article  Google Scholar 

  37. Vegeto, E., C. Bonincontro, G. Pollio, A. Sala, S. Viappiani, F. Nardi, A. Brusadelli, B. Viviani, P. Ciana, and A. Maggi. 2001. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21: 1809–1818.

    CAS  Google Scholar 

  38. Bruce-Keller, A.J., J.L. Keeling, J.N. Keller, F.F. Huang, S. Camondola, and M.P. Mattson. 2000. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141: 3646–3656.

    CAS  PubMed  Google Scholar 

  39. Li, Y., K.A. Burns, Y. Arao, C.J. Luh, and K.S. Korach. 2012. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor alpha and beta in vitro. Environmental Health Perspectives 120: 1029–1035.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  40. Hung, C.H., S.N. Yang, P.L. Kuo, Y.T. Chu, H.W. Chang, W.J. Wei, S.K. Huang, and Y.J. Jong. 2010. Modulation of cytokine expression in human myeloid dendritic cells by environmental endocrine-disrupting chemicals involves epigenetic regulation. Environmental Health Perspectives 118: 67–72.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  41. Stein, B., and M.X. Yang. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Molecular and Cellular Biology 15: 4971–4979.

    CAS  PubMed Central  PubMed  Google Scholar 

  42. Hirano, S., D. Furutama, and T. Hanafusa. 2007. Physiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cells. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 292: R1465–R1471.

    CAS  PubMed  Article  Google Scholar 

  43. Bulayeva, N.N., B. Gametchu, and C.S. Watson. 2004. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69: 181–192.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  44. Watson, C.S., N.N. Bulayeva, A.L. Wozniak, and R.A. Alyea. 2007. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 72: 124–134.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  45. Cobb, M.H., and E.J. Goldsmith. 1995. How MAP kinases are regulated. Journal of Biological Chemistry 270: 14843–14846.

    CAS  PubMed  Article  Google Scholar 

  46. Hohmann, H.P., M. Brockhaus, P.A. Baeuerle, R. Remy, R. Kolbeck, and A.P. van Loon. 1990. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. The Journal of Biological Chemistry 265: 22409–22417.

    CAS  PubMed  Google Scholar 

  47. Classen, A., B.N. Kalali, C. Schnopp, C. Andres, J.A. Aguilar-Pimentel, J. Ring, M. Ollert, and M. Mempel. 2011. TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP-1, and downstream gene transcription. Experimental Dermatology 20: 48–52.

    CAS  PubMed  Article  Google Scholar 

  48. Jongeneel, C.V. 1995. Transcriptional regulation of the tumor necrosis factor α gene. Immunobiology 193: 210–216.

    CAS  PubMed  Article  Google Scholar 

  49. Beg, A.A., S.M. Ruben, R.I. Scheinman, S. Haskill, C.A. Rosen, and A.S. Baldwin. 1992. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes & Development 6: 1899–1913.

    CAS  Article  Google Scholar 

  50. Oeckinghaus, A., M.S. Hayden, and S. Ghosh. 2011. Crosstalk in NF-kappaB signaling pathways. Nature Immunology 12: 695–708.

    CAS  PubMed  Article  Google Scholar 

  51. Lee, S., Y.K. Kim, T.Y. Shin, and S.H. Kim. 2013. Neurotoxic effects of bisphenol AF on calcium-induced ROS and MAPKs. Neurotoxicity Research 23: 249–259.

    CAS  PubMed  Article  Google Scholar 

  52. Cargnello, M., and P.P. Roux. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and Molecular Biology Reviews MMBR 75: 50–83.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  53. Belcher, S.M., H.H. Le, L. Spurling, and J.K. Wong. 2005. Rapid estrogenic regulation of extracellular signal- regulated kinase 1/2 signaling in cerebellar granule cells involves a G protein- and protein kinase A-dependent mechanism and intracellular activation of protein phosphatase 2A. Endocrinology 146: 5397–5406.

    CAS  PubMed  Article  Google Scholar 

  54. Guma, M., D. Stepniak, H. Shaked, M.E. Spehlmann, S. Shenouda, H. Cheroutre, I. Vicente-Suarez, L. Eckmann, M.F. Kagnoff, and M. Karin. 2011. Constitutive intestinal NF-kappaB does not trigger destructive inflammation unless accompanied by MAPK activation. The Journal of Experimental Medicine 208: 1889–1900.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  55. Olajide, O.A., M.A. Aderogba, and B.L. Fiebich. 2013. Mechanisms of anti-inflammatory property of Anacardium occidentale stem bark: inhibition of NF-kappaB and MAPK signalling in the microglia. Journal of Ethnopharmacology 145: 42–49.

    CAS  PubMed  Article  Google Scholar 

Download references

ACKNOWLEDGMENTS

This work was supported by the National Natural Science Foundation of China (81273115, 81072329, and 81202230) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Hang Xiao or Jun Wang.

Additional information

Jingying Zhu and Lei Jiang have contributed equally to this study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhu, J., Jiang, L., Liu, Y. et al. MAPK and NF-κB Pathways Are Involved in Bisphenol A-Induced TNF-α and IL-6 Production in BV2 Microglial Cells. Inflammation 38, 637–648 (2015). https://doi.org/10.1007/s10753-014-9971-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-9971-5

KEY WORDS

  • bisphenol A
  • immunomodulatory cytokines
  • ERβ
  • MAPK
  • NF-κB